[go: up one dir, main page]

BR9813712A - Derivados de n-fenilamida e n-piridilamida, método para preparação dos mesmos e composições farmacêuticas contendo os mesmos - Google Patents

Derivados de n-fenilamida e n-piridilamida, método para preparação dos mesmos e composições farmacêuticas contendo os mesmos

Info

Publication number
BR9813712A
BR9813712A BR9813712-3A BR9813712A BR9813712A BR 9813712 A BR9813712 A BR 9813712A BR 9813712 A BR9813712 A BR 9813712A BR 9813712 A BR9813712 A BR 9813712A
Authority
BR
Brazil
Prior art keywords
phenylamide
preparing
pharmaceutical compositions
compositions containing
pyridylamide
Prior art date
Application number
BR9813712-3A
Other languages
English (en)
Inventor
Didier Festal
Jean Yves Nioche
Guy Augert
Jaques Decerprit
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9813712A publication Critical patent/BR9813712A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C07C57/50—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE N-FENILAMIDA E N-PIRIDILAMIDA, MéTODO PARA PREPARAçãO DOS MESMOS E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS"<D>. A presente invenção refere-se aos compostos de fórmula (I) em que X, R~ 1~, R~ 2~ e R~ 3~ são como definidos na reivindicação 1. Estes compostos são inibidores de acil colesterila transferase (ACAT).
BR9813712-3A 1997-12-23 1998-12-11 Derivados de n-fenilamida e n-piridilamida, método para preparação dos mesmos e composições farmacêuticas contendo os mesmos BR9813712A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716399A FR2772761B1 (fr) 1997-12-23 1997-12-23 Nouveaux derives de n-phenylamide et n-pyridylamide, leur procede de preparation et compositions pharmaceutiques les contenant
PCT/EP1998/008101 WO1999033825A1 (en) 1997-12-23 1998-12-11 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them

Publications (1)

Publication Number Publication Date
BR9813712A true BR9813712A (pt) 2000-12-12

Family

ID=9515039

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813712-3A BR9813712A (pt) 1997-12-23 1998-12-11 Derivados de n-fenilamida e n-piridilamida, método para preparação dos mesmos e composições farmacêuticas contendo os mesmos

Country Status (19)

Country Link
US (2) US6339097B1 (pt)
EP (1) EP1040109A1 (pt)
JP (1) JP2001527073A (pt)
KR (1) KR20010033414A (pt)
CN (1) CN1283196A (pt)
AR (1) AR017896A1 (pt)
AU (1) AU751291B2 (pt)
BR (1) BR9813712A (pt)
CA (1) CA2316382A1 (pt)
FR (1) FR2772761B1 (pt)
HU (1) HUP0004546A3 (pt)
ID (1) ID26506A (pt)
MY (1) MY132969A (pt)
NO (1) NO20003290L (pt)
PL (1) PL341241A1 (pt)
RU (1) RU2214409C2 (pt)
SK (1) SK9312000A3 (pt)
WO (1) WO1999033825A1 (pt)
ZA (1) ZA9811795B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
WO2002047723A1 (fr) * 2000-12-11 2002-06-20 Takeda Chemical Industries, Ltd. Compositions medicamenteuses presentant une meilleure hydrosolubilite
US7939545B2 (en) 2006-05-16 2011-05-10 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
SI2220076T1 (sl) 2007-11-15 2012-05-31 Gilead Sciences Inc Inhibitorji replikacije virusa humane imunske pomankljivosti
AU2008323558C1 (en) 2007-11-16 2014-05-01 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
US8217188B2 (en) * 2008-08-27 2012-07-10 Corning Incorporated 2H-chromenes annelated at C5-C6 and methods of making and using thereof
ES2742261T3 (es) 2011-04-15 2020-02-13 Hivih Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos
EP2821104A1 (en) 2013-07-05 2015-01-07 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
US9968604B2 (en) 2015-04-16 2018-05-15 Chiesi Farmaceutici S.P.A. Chromene derivatives as phoshoinositide 3-kinases inhibitors
EP3759086A1 (en) 2018-02-27 2021-01-06 Artax Biopharma Inc. Chromene derivatives as inhibitors of tcr-nck interaction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225307A (en) * 1987-07-10 1991-06-25 Hoffmann La Roche Heterocyclic containing alkene derivatives and pharmaceutical compositions
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
CA2026389A1 (en) * 1989-09-29 1991-03-30 Hideo Nakai Chromene or thiochromene derivatives, process for preparing the same and intermediate therefor
DE69110828T2 (de) * 1990-10-16 1995-11-30 Takeda Chemical Industries Ltd Heterozyklische Aminderivate, deren Herstellung und deren Verwendung.
NO179904C (no) * 1992-09-04 1997-01-08 Takeda Chemical Industries Ltd Kondenserte heterocykliske forbindelser og deres anvendelse
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
NZ523550A (en) * 2000-07-13 2004-05-28 Takeda Chemical Industries Ltd Lipid-rich plaque inhibitors

Also Published As

Publication number Publication date
WO1999033825A8 (en) 1999-08-26
ID26506A (id) 2001-01-11
FR2772761B1 (fr) 2000-05-26
CN1283196A (zh) 2001-02-07
HUP0004546A2 (hu) 2001-08-28
WO1999033825A1 (en) 1999-07-08
EP1040109A1 (en) 2000-10-04
PL341241A1 (en) 2001-03-26
CA2316382A1 (en) 1999-07-08
KR20010033414A (ko) 2001-04-25
HUP0004546A3 (en) 2002-12-28
US6339097B1 (en) 2002-01-15
SK9312000A3 (en) 2001-04-09
RU2214409C2 (ru) 2003-10-20
US6509362B2 (en) 2003-01-21
US20020068739A1 (en) 2002-06-06
JP2001527073A (ja) 2001-12-25
NO20003290L (no) 2000-08-22
ZA9811795B (en) 1999-06-22
AU2270999A (en) 1999-07-19
AU751291B2 (en) 2002-08-08
NO20003290D0 (no) 2000-06-22
MY132969A (en) 2007-10-31
AR017896A1 (es) 2001-10-24
FR2772761A1 (fr) 1999-06-25

Similar Documents

Publication Publication Date Title
BR0011738A (pt) Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm
BR9911013A (pt) Derivados de pirazol como inibidores da p-38 map quinase
BR0115580A (pt) Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BR0113989A (pt) Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos
BR0010555A (pt) Inibidores de neuraminidases
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
ES2104754T3 (es) Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
BR9813712A (pt) Derivados de n-fenilamida e n-piridilamida, método para preparação dos mesmos e composições farmacêuticas contendo os mesmos
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR0008297A (pt) Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma
BR9909739A (pt) Benzotiadiazóis e derivados
BR9905089A (pt) Derivados macrolìdeos
BR9916669A (pt) Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
BR0012478A (pt) Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos
BR9712707A (pt) Derivados de ácido 4-bifenil-4-hidroxibutìrico substituìdo com inibidores de metaloprotease de matriz
BR9907100A (pt) Pentassacarìdeos, processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR0111669A (pt) Novos compostos
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.